Dragon Jade Internat (DGJI) 5.1000 $DGJI
Dragon Jade in Exclusive Negotiation for SleepMate
PR Newswire - Mon Jan 05, 7:30AM CST
Dragon Jade International Limited (OTCQB: DGJI) (the "Company"
announced today that it is negotiating for the exclusive licensing rights to SleepMate, a medical monitoring application device.
Dragon Jade International Announces New Treatment for Diabetes
PR Newswire - Wed Sep 24, 12:00PM CDT
Dragon Jade International Limited (OTCQB
GJI) (the "Company" , has been acquiring several long established and proven Chinese herbal medicinal products from several long standing Chinese medicine practitioners in China, Hong Kong regions, Taiwan and the USA. The Company is pleased to announce today that it has recently accredited and accepted another Chinese herbal formula that has clinically been proven to treat diabetes. Specifically, the new product has successfully lowered the AC-glucose level and HbA1C of diabetes patients. Consumption of the herbal medicine has demonstrated significant health improvements in patients with Diabetes Mellitus. Diabetes Mellitus is an autoimmune disease that permanently destroys beta cells in the pancreas, meaning that the body can no longer produce insulin, a hormone that enables people to get energy from food. Lack of insulin production by the pancreas makes diabetes a particularly difficult medical condition to treat. Scientists believe that both genetic factors and environmental triggers are involved in its cause. Its onset has nothing to do with diet or lifestyle.
Dragon Jade in Exclusive Negotiation for SleepMate
PR Newswire - Mon Jan 05, 7:30AM CST
Dragon Jade International Limited (OTCQB: DGJI) (the "Company"
announced today that it is negotiating for the exclusive licensing rights to SleepMate, a medical monitoring application device. Dragon Jade International Announces New Treatment for Diabetes
PR Newswire - Wed Sep 24, 12:00PM CDT
Dragon Jade International Limited (OTCQB
GJI) (the "Company" , has been acquiring several long established and proven Chinese herbal medicinal products from several long standing Chinese medicine practitioners in China, Hong Kong regions, Taiwan and the USA. The Company is pleased to announce today that it has recently accredited and accepted another Chinese herbal formula that has clinically been proven to treat diabetes. Specifically, the new product has successfully lowered the AC-glucose level and HbA1C of diabetes patients. Consumption of the herbal medicine has demonstrated significant health improvements in patients with Diabetes Mellitus. Diabetes Mellitus is an autoimmune disease that permanently destroys beta cells in the pancreas, meaning that the body can no longer produce insulin, a hormone that enables people to get energy from food. Lack of insulin production by the pancreas makes diabetes a particularly difficult medical condition to treat. Scientists believe that both genetic factors and environmental triggers are involved in its cause. Its onset has nothing to do with diet or lifestyle. 
